Log in or become a member to contribute to the discussion.
Page type: 
Policy and advocacy
Publication date: 

WHO’s Intersectoral Global Action Plan (IGAP) on epilepsy and other neurological disorders, adopted in May 2022 by the Member states, sets out the actions needed to improve access to care and treatment for people living with neurological disorders through a comprehensive, coordinated response across sectors.

Neurological disorders are the leading cause of disability-adjusted life years* and a 2020 Lancet paper cites them as the second leading cause of death globally, accounting for 9 million deaths a year. Despite the high global burden of neurological conditions, access to both services and support for these conditions is insufficient, especially in low- and middle-income countries.

The action plan outlines five strategic objectives: to raise policy prioritization and strengthen governance; to provide effective, timely and responsive diagnosis, treatment and care; to implement strategies for promotion and prevention; to foster research and innovation and strengthen information systems; and to strengthen the public health approach to epilepsy.

Actions suggested under each strategic objective are aimed at countries and partners, with WHO providing technical support and guidance in the implementation of the plan.

There are 10 global targets with measurable indicators to track the achievement of the objectives by 2031. To achieve these targets, the plan also outlines the close collaboration required between stakeholders in the health sector and beyond, as well as the need to support the participation and empowerment of people with neurological disorders, their carers and families.



How useful did you find this content?: 
Your rating: None
No votes yet

Similar content